Revenue Recognition and Collaborative Arrangements (Tables)

3 Months Ended

Mar. 31, 2018

Revenue Recognition and Collaborative Arrangements

Schedule of revenue from collaborative arrangements

	Three Months Ended March 31,
(In thousands)	2018			2017
Royalties from a related party - RELVAR/BREO	$	46,160		$	38,689
Royalties from a related party - ANORO	8,724			5,038
Royalties from a related party - TRELEGY	952			—
Total royalties from a related party	55,836			43,727
Less: amortization of capitalized fees paid to a related party	(3,456		)	(3,456		)
Royalty revenue	52,380			40,271
Strategic alliance - MABA program license	—			221
Total net revenue from GSK	$	52,380		$	40,492